Emmessar Biotech & Nutrition Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 0.57 | 0.58 | 0.63 |
| Operating Expense | 0.46 | 0.43 | 0.46 |
| Net Profit | 0.03 | 0.12 | 0.11 |
| Net Profit Margin | 5.26% | 20.69% | 17.46% |
| Earning Per Share | 0.01 | 0.23 | 0.23 |
| EBIDTA | 0.11 | 0.18 | 0.18 |
| Effective Tax Rate | 45.45% | 20% | 23.53% |
Particulars
Mar 2026
Revenue0.57
Operating Expense0.46
Net Profit0.03
Net Profit Margin5.26
Earning Per Share0.01
EBIDTA0.11
Effective Tax Rate45.45
